作者
Peter Geon Kim, Abhishek Niroula, Veronica Shkolnik, Marie McConkey, Amy E Lin, Mikołaj Słabicki, John P Kemp, Alexander Bick, Christopher J Gibson, Gabriel Griffin, Aswin Sekar, Daniel J Brooks, Waihay J Wong, Drew N Cohen, Md Mesbah Uddin, Wesley J Shin, James Pirruccello, Jonathan M Tsai, Mridul Agrawal, Douglas P Kiel, Mary L Bouxsein, J Brent Richards, David M Evans, Marc N Wein, Julia F Charles, Siddhartha Jaiswal, Pradeep Natarajan, Benjamin L Ebert
发表日期
2021/10/26
期刊
Journal of Experimental Medicine
卷号
218
期号
12
页码范围
e20211872
出版商
Rockefeller University Press
简介
Osteoporosis is caused by an imbalance of osteoclasts and osteoblasts, occurring in close proximity to hematopoietic cells in the bone marrow. Recurrent somatic mutations that lead to an expanded population of mutant blood cells is termed clonal hematopoiesis of indeterminate potential (CHIP). Analyzing exome sequencing data from the UK Biobank, we found CHIP to be associated with increased incident osteoporosis diagnoses and decreased bone mineral density. In murine models, hematopoietic-specific mutations in Dnmt3a, the most commonly mutated gene in CHIP, decreased bone mass via increased osteoclastogenesis. Dnmt3a−/− demethylation opened chromatin and altered activity of inflammatory transcription factors. Bone loss was driven by proinflammatory cytokines, including Irf3-NF-κB–mediated IL-20 expression from Dnmt3a mutant macrophages. Increased osteoclastogenesis due to the …
引用总数
2020202120222023202411254431
学术搜索中的文章
PG Kim, A Niroula, V Shkolnik, M McConkey, AE Lin… - Journal of Experimental Medicine, 2021